- Home
- NUTX vs INZY Comparison
NUTX vs INZY Comparison
Compare NUTX & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUTX
- INZY
- Stock Information
- Founded
- NUTX 2011
- INZY 2015
- Country
- NUTX United States
- INZY United States
- Employees
- NUTX N/A
- INZY N/A
- Industry
- NUTX Retail: Computer Software & Peripheral Equipment
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- NUTX Technology
- INZY Health Care
- Exchange
- NUTX Nasdaq
- INZY Nasdaq
- Market Cap
- NUTX 182.2M
- INZY 188.2M
- IPO Year
- NUTX N/A
- INZY 2020
- Fundamental
- Price
- NUTX $37.81
- INZY $1.36
- Analyst Decision
- NUTX Strong Buy
- INZY Strong Buy
- Analyst Count
- NUTX 2
- INZY 8
- Target Price
- NUTX $55.00
- INZY $17.75
- AVG Volume (30 Days)
- NUTX 25.0K
- INZY 784.0K
- Earning Date
- NUTX 11-07-2024
- INZY 03-11-2025
- Dividend Yield
- NUTX N/A
- INZY N/A
- EPS Growth
- NUTX N/A
- INZY N/A
- EPS
- NUTX N/A
- INZY N/A
- Revenue
- NUTX $292,000,390.00
- INZY N/A
- Revenue This Year
- NUTX $25.00
- INZY N/A
- Revenue Next Year
- NUTX $14.40
- INZY N/A
- P/E Ratio
- NUTX N/A
- INZY N/A
- Revenue Growth
- NUTX 26.02
- INZY N/A
- 52 Week Low
- NUTX $4.16
- INZY $1.32
- 52 Week High
- NUTX $41.44
- INZY $7.80
- Technical
- Relative Strength Index (RSI)
- NUTX 63.48
- INZY 20.27
- Support Level
- NUTX $28.82
- INZY $1.32
- Resistance Level
- NUTX $35.94
- INZY $3.18
- Average True Range (ATR)
- NUTX 2.18
- INZY 0.27
- MACD
- NUTX 0.47
- INZY -0.15
- Stochastic Oscillator
- NUTX 77.57
- INZY 2.15
About NUTX Nutex Health Inc.
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Incclinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. The company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 Deficiencies. The company product candidate, INZ-701, is a soluble, recombinant, genetically engineered, fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 Deficiencies.